MRVI

SEC source: 0001823239-24-000074 · wk-form4_1716587865.xml · nonDerivative · entry 1

MARKER LUKE JOSEPH · CIK 0001829810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,916

F1 · shares: Represents restricted stock units granted on May 23, 2024, which vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.

SEC source: 0001823239-24-000072 · wk-form4_1716587818.xml · nonDerivative · entry 1

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,768

F1 · shares: Represents restricted stock units granted on May 23, 2024, which vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

SEC source: 0001823239-24-000054 · wk-form4_1714689973.xml · nonDerivative · entry 1

BURCH ANDREW · CIK 0001970770 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 421,754

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,719 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-24-000053 · wk-form4_1714689958.xml · nonDerivative · entry 1

Dolan Christine · CIK 0001684273 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,490

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 483 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-24-000055 · wk-form4_1714689986.xml · nonDerivative · entry 1

Herde Kevin · CIK 0001671595 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 334,694

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,780 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-24-000052 · wk-form4_1714689934.xml · nonDerivative · entry 1

Leddy Peter Michael · CIK 0001332202 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,935

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 4,576 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-24-000056 · wk-form4_1714690001.xml · nonDerivative · entry 1

ORESHACK KURT · CIK 0001832579 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,690

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 341 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-24-000046 · wk-form4_1713304888.xml · nonDerivative · entry 1

BURCH ANDREW · CIK 0001970770 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,035

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000040 · wk-form4_1710799105.xml · nonDerivative · entry 1

Dolan Christine · CIK 0001684273 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,007

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000036 · wk-form4_1710798913.xml · nonDerivative · entry 1

Herde Kevin · CIK 0001671595 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,914

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000034 · wk-form4_1710798854.xml · nonDerivative · entry 1

HULL CARL · CIK 0001205465 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,072

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000038 · wk-form4_1710798985.xml · nonDerivative · entry 1

Leddy Peter Michael · CIK 0001332202 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,359

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000044 · wk-form4_1710799246.xml · nonDerivative · entry 1

BUZZEO REBECCA · CIK 0001970970 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,066

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000042 · wk-form4_1710799171.xml · nonDerivative · entry 1

ORESHACK KURT · CIK 0001832579 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,349

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000024 · wk-form4_1708472802.xml · nonDerivative · entry 1

Dolan Christine · CIK 0001684273 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,390

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000025 · wk-form4_1708472810.xml · nonDerivative · entry 1

Herde Kevin · CIK 0001671595 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,538

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000023 · wk-form4_1708472789.xml · nonDerivative · entry 1

HULL CARL · CIK 0001205465 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,632

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000026 · wk-form4_1708472817.xml · nonDerivative · entry 1

ORESHACK KURT · CIK 0001832579 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,900

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-24-000018 · wk-form4_1705620742.xml · nonDerivative · entry 1

BURCH ANDREW · CIK 0001970770 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 436,793

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000006 · wk-form4_1705620081.xml · nonDerivative · entry 1

Dolan Christine · CIK 0001684273 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,331

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000010 · wk-form4_1705620365.xml · nonDerivative · entry 1

Herde Kevin · CIK 0001671595 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 344,202

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000008 · wk-form4_1705620203.xml · nonDerivative · entry 1

HULL CARL · CIK 0001205465 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,361

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000014 · wk-form4_1705620559.xml · nonDerivative · entry 1

Leddy Peter Michael · CIK 0001332202 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,073

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000016 · wk-form4_1705620637.xml · nonDerivative · entry 1

MARTIN WILLIAM E. III · CIK 0001949513 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,040,273

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000012 · wk-form4_1705620473.xml · nonDerivative · entry 1

ORESHACK KURT · CIK 0001832579 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,222

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000004 · wk-form4_1705620001.xml · nonDerivative · entry 1

BUZZEO REBECCA · CIK 0001970970 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,432

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-23-000094 · wk-form4_1700173279.xml · nonDerivative · entry 1

BUZZEO REBECCA · CIK 0001970970 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,234

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-23-000095 · wk-form4_1700173298.xml · nonDerivative · entry 1

Dolan Christine · CIK 0001684273 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,727

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,729 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-23-000096 · wk-form4_1700173315.xml · nonDerivative · entry 1

Herde Kevin · CIK 0001671595 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,925

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,861 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-23-000097 · wk-form4_1700173332.xml · nonDerivative · entry 1

Leddy Peter Michael · CIK 0001332202 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,796

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 449 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-23-000085 · wk-form4_1697577134.xml · nonDerivative · entry 1

MARTIN WILLIAM E. III · CIK 0001949513 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,858

F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-23-000083 · wf-form4_169273574241776.xml · derivative · entry 1

MARTIN WILLIAM E. III · CIK 0001949513 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Class A Common Stock · 300,000 shares

Expires 2026-08-21

F1 · derivative.exercise_price: Represents performance-based restricted stock units ("PSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan (the "Omnibus Incentive Plan"). Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest on August 21, 2026, if and to the extent the volume-weighted average price of a share of the Class A Common Stock of the Issuer equals or exceeds certain thresholds for the 60 consecutive trading days immediately preceding August 21, 2026, provided that in the event of a Change in Control (as defined in the Omnibus Incentive Plan) prior to August 21, 2026, the PSUs will convert to time-based restricted stock units that will fully vest on August 21, 2026, subject to the Reporting Person's continued employment with the Issuer through such date.

F1 · derivative.exercise_date: Represents performance-based restricted stock units ("PSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan (the "Omnibus Incentive Plan"). Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest on August 21, 2026, if and to the extent the volume-weighted average price of a share of the Class A Common Stock of the Issuer equals or exceeds certain thresholds for the 60 consecutive trading days immediately preceding August 21, 2026, provided that in the event of a Change in Control (as defined in the Omnibus Incentive Plan) prior to August 21, 2026, the PSUs will convert to time-based restricted stock units that will fully vest on August 21, 2026, subject to the Reporting Person's continued employment with the Issuer through such date.

SEC source: 0001823239-23-000075 · wf-form4_168997112890875.xml · nonDerivative · entry 1

DeFord John A · CIK 0001403373 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,901

F1 · shares: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of July 20, 2024, July 20, 2025, and July 20, 2026, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.

SEC source: 0001823239-23-000061 · wf-form4_168979977707285.xml · nonDerivative · entry 1

Ashkenazi Anat · CIK 0001761679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,123

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

SEC source: 0001823239-23-000058 · wf-form4_168979972286568.xml · nonDerivative · entry 1

MIHAS CONSTANTINE S · CIK 0001262930 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,271

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.

SEC source: 0001823239-23-000060 · wf-form4_168979975930213.xml · nonDerivative · entry 1

LUCIER GREGORY T · CIK 0001251299 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,123

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

SEC source: 0001823239-23-000064 · wf-form4_168979982400912.xml · nonDerivative · entry 2

Leddy Peter Michael · CIK 0001332202 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,347

F2 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

SEC source: 0001823239-23-000065 · wf-form4_168979983995803.xml · nonDerivative · entry 1

Hopfield Jessica · CIK 0001648715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,123

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

SEC source: 0001823239-23-000063 · wf-form4_168979980913958.xml · nonDerivative · entry 1

CUNNINGHAM SEAN LAURENCE · CIK 0001829753 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,271

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.

SEC source: 0001823239-23-000062 · wf-form4_168979979386639.xml · nonDerivative · entry 1

PRAHALAD MURALI · CIK 0001829991 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,823

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

SEC source: 0001823239-23-000059 · wf-form4_168979974373678.xml · nonDerivative · entry 1

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,123

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

SEC source: 0001823239-23-000057 · wf-form4_168979969691623.xml · nonDerivative · entry 1

MARKER LUKE JOSEPH · CIK 0001829810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,271

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.

SEC source: 0001823239-23-000056 · wf-form4_168979968066320.xml · nonDerivative · entry 1

DAVERMAN BENJAMIN JAMES · CIK 0001829768 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,271

F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

F2 · balance_after: The Reporting Person holds these securities of the Issuer for the benefit of a GTCR-affiliated entity. Pursuant to the policies of the GTCR-affiliated entities, the Reporting Person must hold the securities on behalf of and for the benefit of the GTCR-affiliated entity. The Reporting Person disclaims any pecuniary interest in the securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16.

SEC source: 0001823239-23-000066 · wf-form4_168979985673798.xml · nonDerivative · entry 1

Dolan Christine · CIK 0001684273 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,998

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,394 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-23-000068 · wf-form4_168979989281869.xml · nonDerivative · entry 1

Herde Kevin · CIK 0001671595 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,064

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 874 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-23-000064 · wf-form4_168979982400912.xml · nonDerivative · entry 1

Leddy Peter Michael · CIK 0001332202 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,925

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,920 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-23-000067 · wf-form4_168979987715577.xml · nonDerivative · entry 1

ORESHACK KURT · CIK 0001832579 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,370

F1 · kind: The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,014 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

SEC source: 0001823239-24-000002 · wk-form5_1705619708.xml · derivative · entry 2

BURCH ANDREW · CIK 0001970770 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Class A Common Stock · 80,000 shares

Expires 2033-04-17

F2 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 25% on April 15, 2024 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-24-000002 · wk-form5_1705619708.xml · nonDerivative · entry 1

BURCH ANDREW · CIK 0001970770 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,011

F1 · price: Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of April 15, 2024, April 15, 2025, and April 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

SEC source: 0001823239-23-000027 · wf-form4_167908630038670.xml · derivative · entry 2

Dolan Christine · CIK 0001684273 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2033-03-15

F2 · derivative.exercise_date: Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on April 15, 2023 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.